Sangamo Therapeutics, Inc. (SGMO) - Forvard P/S multiplikatori

Sangamo Therapeutics Inc. (SGMO) kompaniyasining korporativ logotipi

Sangamo Therapeutics (SGMO) kompaniyasining foyda olish salohiyati sink barmog'i texnologiyalarini litsenziyalashga va sanoat gigantlaridan keladigan to'lovlarga bog'liq. Dori vositalarini ishlab chiqish AI yordamida avtomatlashtirilgan, garchi yakuniy testlar shifokorlarning ishtirokini talab qilsa-da. Sotuvlarga nisbatan prognoz qilingan narx koeffitsiyenti tendentsiyasi joriy bozor dinamikasini aks ettiradi, bunda 1.90 ko'rsatkichning tegishli qiymatidir. Ushbu grafik kompaniyaning kuchli ilmiy xodimlari va patent portfelini ta'kidlaydi.

SGMO sangamo.com: Sotuvga nisbatan forvard narx 04.07.2022 - 09.05.2026 oraligʻida

Sangamo Therapeutics (SGMO) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning dastlabki tahlili:Sangamo Therapeutics Inc. (SGMO)
Sangamo BioSciences original mahsuloti

Forward P/S ko'rsatkichi bozor kapitalizatsiyasini kutilayotgan savdo hajmi bilan nisbatda o'lchaydi, bu esa investorlarga narxga kiritilgan optimizm darajasini va kelajakdagi daromadlar uchun haddan tashqari ko'p to'lash xavfini baholash imkonini beradi. Sangamo Therapeutics (SGMO) uchun forward price-to-sales tahlili "zinc finger" patent himoyasi va cho'zilgan tartibga solish sikllarining ta'sirini hisobga oladi, bu esa bozor kutuvlari va texnologik to'siqlar muvozanati orqali biznesning fundamental barqarorligini tasdiqlaydi.

Sangamo Therapeutics raqobatchilari

Forvard P/S multiplikatori TEM (Tempus Labs)|Qiagen N.V. - Narxning prognoz qilingan daromadga nisbati|IONS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati repligen.com|RNA: Forvard P/S multiplikatori|CRISPR Therapeutics Inc (CRSP) - Forvard P/S multiplikatori|WGS (GeneDx Holdings) - Forvard P/S multiplikatori|RARE: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori BEAM (Beam Therapeutics Corp)|SRPT: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori TWST (Twist Bioscience Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati 10x Genomics Corp (TXG)|intelliatx.com - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Stoke STOK|biolifesolutions.com (BLFS) - Narxning prognoz qilingan daromadga nisbati|WVE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori MAZE|Forvard narx/daromad multiplikatori Sionna Therapeutics, Inc. (SION)|Forvard narx/daromad multiplikatori PRME (Prime Medicine Bio)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Taysha|uniQure Pharma - Forvard narx/daromad multiplikatori|MeiraGTx Holdings plc - Narxning prognoz qilingan daromadga nisbati|regenxbio.com - Forvard P/S multiplikatori|Solid Bio (SLDB) - Forvard narx/daromad multiplikatori|OCGN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati DSGN (Design Therapeutics)|Forvard P/S multiplikatori RCKT|Narxning prognoz qilingan daromadga nisbati FDMT (4D Molecular Therapeutics Inc)|Forvard P/S multiplikatori LXEO (Lexeo Therapeutics Inc.)|Sotuvga nisbatan forvard narx KRRO|EDIT - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Silence Therapeutics SLN|ProQR Therapeutics NV (PRQR) - Narxning prognoz qilingan daromadga nisbati|Codexis Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Nautilus Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Metagenomi Therapeutics MGX|Narxning prognoz qilingan daromadga nisbati Precision BioSciences (DTIL)|GBIO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori BOLD (Boundless Bio, Inc)|XCUR - Forvard narx/daromad multiplikatori|IMNN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Phio Pharmaceuticals Corp|MBIO: Forvard P/S multiplikatori|TransCode (RNAZ) - Forvard P/S multiplikatori|BNGO (Bionano) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Applied DNA Sciences, Inc. APDN|Forvard P/S multiplikatori BLUE|ImmunoPrecise Antibodies Ltd - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omega Therapeutics OMGA|OMIC: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGLS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON)|Narxning prognoz qilingan daromadga nisbati Unity Biotechnology, Inc.